Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 26 2025
0mins
Should l Buy ?
Source: Globenewswire
Webinar Announcement: Nexalin Technology, Inc. is hosting a webinar on April 3, 2025, featuring CEO Mark White discussing the company's advancements in non-invasive neurostimulation devices and their clinical data supporting treatments for mental health conditions like insomnia and PTSD.
Company Overview: Nexalin develops innovative neurostimulation products aimed at addressing mental health issues, with its Gen-2 device already approved in several countries and a focus on enhancing patient response through deeper brain penetration without adverse side effects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
